159 related articles for article (PubMed ID: 1752407)
1. [Plasma cell myeloma. I. A new concept of disease biology].
Barlogi B; Epstein J; Selvaniagam P; Alexanian R
Gematol Transfuziol; 1991 Aug; 36(8):29-35. PubMed ID: 1752407
[No Abstract] [Full Text] [Related]
2. Multiple myeloma: increasing evidence for a multistep transformation process.
Hallek M; Bergsagel PL; Anderson KC
Blood; 1998 Jan; 91(1):3-21. PubMed ID: 9414264
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma: why does the disease escape from plateau phase?
Joshua DE; Brown RD; Gibson J
Br J Haematol; 1994 Dec; 88(4):667-71. PubMed ID: 7819092
[No Abstract] [Full Text] [Related]
4. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
Klein B; Seckinger A; Moehler T; Hose D
Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
[TBL] [Abstract][Full Text] [Related]
5. In which cells does neoplastic transformation occur in myelomatosis?
MacLennan IC
Curr Top Microbiol Immunol; 1992; 182():209-14. PubMed ID: 1490356
[No Abstract] [Full Text] [Related]
6. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma: biology of the disease.
Mahindra A; Hideshima T; Anderson KC
Blood Rev; 2010 Nov; 24 Suppl 1():S5-11. PubMed ID: 21126636
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of brain tumors.
Wu JK; Naber SP
Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: almost all patients are cytogenetically abnormal.
Zandecki M; Laï JL; Facon T
Br J Haematol; 1996 Aug; 94(2):217-27. PubMed ID: 8759879
[No Abstract] [Full Text] [Related]
10. Functional significance of genetic abnormalities in multiple myeloma.
Gadó K; Domján G; Kormos L; Falus A
Haematologia (Budap); 2002; 32(3):191-208. PubMed ID: 12611480
[TBL] [Abstract][Full Text] [Related]
11. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell myeloma: biology and treatment.
Bergsagel DE
Annu Rev Med; 1991; 42():167-78. PubMed ID: 2035963
[TBL] [Abstract][Full Text] [Related]
13. Multistep tumorigenesis of multiple myeloma: its molecular delineation.
Iida S; Ueda R
Int J Hematol; 2003 Apr; 77(3):207-12. PubMed ID: 12731662
[TBL] [Abstract][Full Text] [Related]
14. From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells.
van Nieuwenhuijzen N; Spaan I; Raymakers R; Peperzak V
Cancer Res; 2018 May; 78(10):2449-2456. PubMed ID: 29703720
[TBL] [Abstract][Full Text] [Related]
15. [Genetic principles of malignant transformation].
Maly K
Acta Med Austriaca; 1992; 19(4):91-5. PubMed ID: 1290321
[TBL] [Abstract][Full Text] [Related]
16. Plasma cell karyotype in multiple myeloma.
Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.
Rasmussen T; Theilgaard-Mönch K; Hudlebusch HR; Lodahl M; Johnsen HE; Dahl IM
Br J Haematol; 2003 Oct; 123(2):253-62. PubMed ID: 14531906
[TBL] [Abstract][Full Text] [Related]
18. Etiology of multiple myeloma: what's new.
Berenson JR
Semin Oncol; 1999 Oct; 26(5 Suppl 13):2-9. PubMed ID: 10528889
[TBL] [Abstract][Full Text] [Related]
19. Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Ernst TJ; Gazdar A; Ritz J; Shipp MA
Blood; 1988 Oct; 72(4):1163-7. PubMed ID: 3048435
[TBL] [Abstract][Full Text] [Related]
20. [Oncogenes and tumor suppressor genes: genetic changes mark the adenoma-carcinoma sequence].
Schmiegel WH
Internist (Berl); 1991 Jun; 32(6):315-20. PubMed ID: 1652573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
